Improve Screening Criteria for Retinopathy of Prematurity in Two French Center
DEREP3
Evaluation of the Criteria and Modalities of Screening for Retinopathy of Prematurity in Two French Tertiary NICU : is a Simplification Possible ?
1 other identifier
observational
886
1 country
1
Brief Summary
The aim of the study is to assess whether a delay of the first examination can be safely considered in French population. Secondary objectives are to describe retinopathy of prematurity (ROP) in a population of premature from two French tertiary NICU and to identify co-morbidities associated with the development of severe ROP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedStudy Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2022
CompletedNovember 26, 2024
September 1, 2022
3 months
November 19, 2021
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of infants with type 1 or 2 ROP found at routine screening.
Number
Day 0
Secondary Outcomes (3)
Time from first retinal examination to treatment of ROP
Day 0
Postnatal age / SAC at first by gestational age
Day 0
Time from first retinal examination to diagnostic of severe ROP
Day 0
Interventions
Eligibility Criteria
Cohort will be selected among all premature born between January 2016 and November 2020 and hospitalized in Centre Hospitalier Sud Francilien (Corbeil Essonnes 91) and Hopital Robert Debré (Paris 75).
You may qualify if:
- Infant with gestational age \< 31 weeks and/or birth weight \< 1250 g
- With at least one retinal examination
- holders of the parental rights informed and not objecting to the study
You may not qualify if:
- infants died before 28 days PNA
- infants with hydrocephaly.
- infants with significant congenital malformations or genetic abnormalities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LEROUX Pauline
Corbeil-Essonnes, France, 91106, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pauline LEROUX, MD
Centre Hospitalier Sud Francilien
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2021
First Posted
December 10, 2021
Study Start
March 21, 2022
Primary Completion
June 16, 2022
Study Completion
June 16, 2022
Last Updated
November 26, 2024
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share